Thomas A. Zanardi

662 total citations
13 papers, 492 citations indexed

About

Thomas A. Zanardi is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Thomas A. Zanardi has authored 13 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Genetics. Recurrent topics in Thomas A. Zanardi's work include Advanced biosensing and bioanalysis techniques (5 papers), DNA and Nucleic Acid Chemistry (4 papers) and RNA Interference and Gene Delivery (4 papers). Thomas A. Zanardi is often cited by papers focused on Advanced biosensing and bioanalysis techniques (5 papers), DNA and Nucleic Acid Chemistry (4 papers) and RNA Interference and Gene Delivery (4 papers). Thomas A. Zanardi collaborates with scholars based in United States and South Korea. Thomas A. Zanardi's co-authors include Scott P. Henry, Patrick B. Lappin, Rosie Z. Yu, Wendy Halpern, Marta L. Corcoran, John Zhong, Wendy Cai, Kevin P. Baker, Punit P. Seth and Noah Post and has published in prestigious journals such as Nucleic Acids Research, Journal of Molecular Biology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas A. Zanardi

12 papers receiving 481 citations

Peers

Thomas A. Zanardi

IMMUN

RHEUM

RNMI

SURGE

M Dimitrijevic Serbia

Ju‐Pi Li Taiwan

Leslimar Ríos-Colón United States

Daniel Torres‐Moreno Spain

Taher E. Taher United Kingdom

Maria Radanova Bulgaria

Aarti Damle United States

Yongjing Cheng China

C. Ewel United States

Hongzhen Zhong China

M Dimitrijevic Serbia

Thomas A. Zanardi

135 ×0.5

111 ×1.0

IMMUN

175 ×2.3

RHEUM

43 ×0.6

RNMI

53 ×1.0

SURGE

Citations per year, relative to Thomas A. Zanardi Thomas A. Zanardi (= 1×) peers M Dimitrijevic

Countries citing papers authored by Thomas A. Zanardi

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Zanardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Zanardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Zanardi more than expected).

Fields of papers citing papers by Thomas A. Zanardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Zanardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Zanardi. The network helps show where Thomas A. Zanardi may publish in the future.

Co-authorship network of co-authors of Thomas A. Zanardi

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Zanardi. A scholar is included among the top collaborators of Thomas A. Zanardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Zanardi. Thomas A. Zanardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mazur, Curt, Oleksandr Platoshyn, Sebastien A. Burel, et al.. (2025). Acute neuronal inhibition response caused by phosphorothioate antisense oligonucleotides following local delivery to the central nervous system. Nucleic Acids Research. 54(3).

Zanardi, Thomas A., Laura Boone, Yanfeng Wang, et al.. (2021). Safety, Pharmacokinetic, and Pharmacodynamic Evaluation of a 2′-(2-Methoxyethyl)-D-ribose Antisense Oligonucleotide–Triantenarry N-Acetyl-galactosamine Conjugate that Targets the Human Transmembrane Protease Serine 6. Journal of Pharmacology and Experimental Therapeutics. 377(1). 51–63. 7 indexed citations

Bhattacharjee, Gourab, Alexey S. Revenko, Thomas A. Zanardi, et al.. (2019). IONIS-PKK _Rx a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production. Nucleic Acid Therapeutics. 29(2). 82–91. 28 indexed citations

Zanardi, Thomas A., et al.. (2018). Chronic Toxicity Assessment of 2′- O -Methoxyethyl Antisense Oligonucleotides in Mice. Nucleic Acid Therapeutics. 28(4). 233–241. 16 indexed citations

Shemesh, Colby S., Rosie Z. Yu, Hans Gaus, et al.. (2016). Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys. Molecular Therapy — Nucleic Acids. 5. e319–e319. 46 indexed citations

Yu, Rosie Z., Mark Graham, Noah Post, et al.. (2016). Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice. Molecular Therapy — Nucleic Acids. 5. e317–e317. 73 indexed citations

Yu, Rosie Z., Rudy Gunawan, Noah Post, et al.. (2016). Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys. Nucleic Acid Therapeutics. 26(6). 372–380. 63 indexed citations

Szalai, Alexander J., Mark A. McCrory, Dongqi Xing, et al.. (2014). Inhibiting C-Reactive Protein for the Treatment of Cardiovascular Disease: Promising Evidence from Rodent Models. Mediators of Inflammation. 2014. 1–9. 31 indexed citations

Zanardi, Thomas A., et al.. (2012). Pharmacodynamics and Subchronic Toxicity in Mice and Monkeys of ISIS 388626, a Second-Generation Antisense Oligonucleotide That Targets Human Sodium Glucose Cotransporter 2. Journal of Pharmacology and Experimental Therapeutics. 343(2). 489–496. 42 indexed citations

10.

Henry, Scott P., Mark D. Johnson, Thomas A. Zanardi, et al.. (2012). Renal uptake and tolerability of a 2′-O-methoxyethyl modified antisense oligonucleotide (ISIS 113715) in monkey. Toxicology. 301(1-3). 13–20. 44 indexed citations

11.

Halpern, Wendy, Patrick B. Lappin, Thomas A. Zanardi, et al.. (2006). Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects. Toxicological Sciences. 91(2). 586–599. 113 indexed citations

12.

Lentz, Michael, et al.. (2002). Functional analysis of a carboxyl-terminal phosphorylation mutant of the bovine papillomavirus E1 protein. Journal of Molecular Biology. 316(3). 599–609. 6 indexed citations

13.

Zanardi, Thomas A., et al.. (1997). Modulation of Bovine Papillomavirus DNA Replication by Phosphorylation of the Viral E1 Protein. Virology. 228(1). 1–10. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact